Constellation Brands Investing Cash Flow increased by 437.0% to $660.90M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 237.6%, from -$480.20M to $660.90M. Over 2 years (FY 2022 to FY 2024), Investing Cash Flow shows a downward trend with a 11.4% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$116.60M | -$260.50M | -$297.10M | -$361.60M | -$226.80M | -$259.20M | -$160.60M | -$352.80M | -$291.90M | -$309.00M | -$329.00M | -$356.00M | -$377.40M | -$480.20M | -$240.60M | -$196.10M | $660.90M |
| QoQ Change | — | -123.4% | -14.0% | -21.7% | +37.3% | -14.3% | +38.0% | -119.7% | +17.3% | -5.9% | -6.5% | -8.2% | -6.0% | -27.2% | +49.9% | +18.5% | +437.0% |
| YoY Change | — | — | — | — | -94.5% | +0.5% | +45.9% | +2.4% | -28.7% | -19.2% | -104.9% | -0.9% | -29.3% | -55.4% | +26.9% | +48.0% | +237.6% |